• 1
    LeRoith D (ed). Insulin-Like Growth Factors:Molecular and Cellular Aspects. Boca Raton: CRC Press, 1991.
  • 2
    Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 1991; 5: 318.
  • 3
    Roth RA. Structure of the receptor for insulin-like growth factor II: the puzzle amplified. Science 1988; 239: 12691271.
  • 4
    Czech MP. Signal transmission by the insulin-like growth factors. Cell 1989; 59: 235238.
  • 5
    Neely EK, Beukers MW, Oh Y, Cohen P, Rosenfeld RG. Insulin-like growth factor receptors. Acta Paediatr Scand 1991; 372 (suppl): 116123.
  • 6
    Nissley P, Kiess W, Sklar MM. The IGF-II/mannose-6-phosphate receptor. In: LeRoithD, ed. Insulin-Like Growth Factors: Molecular and Cellular Aspects. Boca Raton: CRC Press, 1991: 111150.
  • 7
    Moxham C, Jacobs S. Insulin-like growth factor receptors. In: SchofieldPN, ed. The Insulin-Like Growth Factors: Structure and Biological Functions. Oxford: Oxford University Press, 1992: 80110.
  • 8
    Kornfeld S. Structure and function of the M6P/IGF-II receptors. Annu Rev Biochem 1992; 61: 307330.
  • 9
    Morgan DO, Jarnagin K, Roth RA. Purification and characterization of the receptor for insulin-like growth factor I. Biochemistry 1986; 25: 55605564.
  • 10
    Ullrich A, Gray A, Tarn AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986; 5: 25032512.
  • 11
    Morgan DO, Edman JC, Standring DR, Fried VA, Smith MC, Roth RA, Rutter WJ. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 1987; 329: 301307.
  • 12
    Soares MB, Ishii DN, Efstriatiadis A. Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA. Nucleic Acids Res 1985; 14: 11291134.
  • 13
    Gray A, Tarn AW, Dull TJ, Hayflick J, Pintar J, Cavenee WK, Koufos A, et al. Tissue-specific and developmentally regulated transcription of the insulin-like growth factor II gene. DNA 1987; 6: 283295.
  • 14
    DeChiara TM, Robertson EJ, Efstriatiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991; 64: 849859.
  • 15
    Giannoukakis N, Deal C, Pacquette J, Goodyer C, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nat Genet 1993; 4: 98101.
  • 16
    Fu XX, Su CY, Lee Y, Hintz R, Biempica L, Snyder R, Rogler CE. Insulin-like growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. J Virol 1988; 62: 34223430.
  • 17
    Yang DY, Rogler CE. Analysis of insulin-like growth factor II (IGF II) expression in neoplastic nodules and hepatocellular carcinomas of wood-chucks utilizing “in situ” hybridization and immunocytochemistry. Carcinogenesis 1991; 12: 18931901.
  • 18
    Norstedt G, Levinovitz A, Moller C, Eriksson LC, Andersson G. Expression of insulin-like growth factor I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat. Carcinogenesis 1988; 9: 209213.
  • 19
    Ueno T, Takahashi K, Matsuguchi T, Ikejiri K, Endo H, Yamamoto M. Reactivation of insulin-like growth factor II gene during hepatocarcinogenesis. Carcinogenesis 1988; 9: 17791783.
  • 20
    Schirmacher P, Held WA, Chisari F, Rustum Y, Wang H-P, Yang D, Rogler CE. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 1992; 52: 25492556.
  • 21
    Cariani E, Laserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP, et al. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors and liver cirrhosis. Cancer Res 1988; 48: 68446849.
  • 22
    Cariani E, Laserre C, Kemeny F, Franco D, Brechot C. Differential expression of insulin-like growth factor II, a-fetoprotein and hepatitis B virus transcripts in human primary liver cancer. Hepatology 1991; 13: 644649.
  • 23
    Derrico A, Grigioni WF, Fiorentino M, Baccarini P, Lamas E, Demitri S, Gozzetti G, et al. Expression of insulin-like growth factor II (IGF II) in human hepatocellular carcinomas: an immunohistochemical study. Pathol Int 1944; 44: 131137.
  • 24
    Su Q, Liu YF, Zhang J-F, Zhang S-X, Li D-F, Yang J-J. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 1994; 19: 788799.
  • 25
    Schirmacher P, Rogler CE, Dienes HP. Current pathogenic and molecular concepts in viral liver carcinogenesis. Virchows Arch B Cell Pathol 1993; 63: 7189.
  • 26
    Opie EL. The pathogenesis of tumors of the liver produced by butter yellow. J Exp Med 1944; 80: 231246.
  • 27
    Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene and 3′-methyl-4-diniethylaminoazobenzene. Cancer Res 1956; 16: 142148.
  • 28
    Dempo K, Chisaka N, Yoshida Y, Kaneko A, Onoe T. Immunofluorescent study on alpha-fetoprotein-producing cells in the early stage of 3′-methyl-4-diniethylaminoazobenzene carcinogenesis. Cancer Res 1975; 32: 12821287.
  • 29
    Sell S. Distribution of alpha-fetoprotein and albumin containing cells in the livers of Fischer rats fed four cycles of JV-2-fluorenylacetamide. Cancer Res 1978; 38: 31073113.
  • 30
    Shinozuka H, Lombardi B, Sell S, lammarino RM. Early histological and functional alterations of ethionine liver carcinogen esis in rats fed a choline-devoid diet. Cancer Res 1978; 38: 10921098.
  • 31
    Steinberg P, Hacker HJ, Dienes HP, Oesch F, Bannasch P. Enzyme histochemical and immunohistochemical characterization of oval and parenchy-mal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 1991; 12: 225231.
  • 32
    Fausto N, Thompson NL, Braun L. Purification and culture of oval cells from rat liver. In: PretlowIITG, PretlowTP, eds. Cell Separation: Methods and Selected Applications. Orlando: Academic, 1987: 4577.
  • 33
    Fausto N. Hepatocyte differentiation and liver progenitor cells. Curr Opin Cell Biol 1990; 2: 10361042.
  • 34
    Evarts RP, Nagy P, Marsden ER, Thorgeirsson SS. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987; 8: 17371740.
  • 35
    Evarts RP, Nagy P, Nakatsukasa H, Marsden ER, Thorgeirsson SS. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 1989; 49: 15411547.
  • 36
    Tsao MS, Grisham JW. Hepatocarcinomas, cholangiocarcinomas and hepatoblastomas produced by chemically transformed rat liver epithelial cells. A light- and electron-microscopic analysis. Am J Pathol 1987; 127: 168181.
  • 37
    Braun L, Goyette M, Yaswen P, Thompson NL, Fausto N. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats. Cancer Res 1987; 47: 41164124.
  • 38
    Braun L, Mikumo R, Fausto N. Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-rnyc andp53 at different stages of oval cell transformation. Cancer Res 1989; 49: 15541561.
  • 39
    Pack R, Heck R, Dienes HP, Oesch F, Steinberg P. Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. Exp Cell Res 1993; 204: 198209.
  • 40
    Steinberg P, Steinbrecher R, Radaeva S, Schirmacher P, Dienes HP, Oesch F, Bannasch P. Oval cell lines OC/CDE 6 and OC/CDE 22 give rise to cholangiocellular and undifferentiated carcinomas after transformation. Lab Invest 1994; 71: 700709.
  • 41
    Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thorgeirsson SS. Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 1992; 16: 13271333.
  • 42
    Hsia CC, Thorgeirsson SS, Tabor E. Expression of hepatitis B surface and core antigens and transforming growth factor-a in “oval cells” of the liver in patients with hepatocellular carcinoma. J Med Virol 1994; 43: 216221.
  • 43
    De Vos R, Desmet V. Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. Am J Pathol 1992; 140: 14411451.
  • 44
    Lee PDK, Hodges D, Hintz RL, Wyche JH, Rosenfeld RG. Identification of receptors for insulin-like growth factor II in two insulin-like growth factor II producing cell lines. Biochem Biophys Res Commun 1986; 134: 595600.
  • 45
    Nissley SP, Short PA, Rechler MM, Podskalny JM, Coon HG. Proliferation of Buffalo rat liver cells in serum-free medium does not depend upon multiplication-stimulating activity (MSA). Cell 1977; 11: 441446.
  • 46
    Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts CT Jr, LeRoith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A 1989; 86: 74517455.
  • 47
    Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 613.
  • 48
    Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 52945299.
  • 49
    SambrookJ, FritschEF, ManiatisT, eds. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989.
  • 50
    Artelt P, Morelle C, Ausmeier M, Fitzek M, Hauser H. Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene 1988; 68: 213219.
  • 51
    Gunning P, Leavitt J, Muscat G, Ng S-Y, Kedes L. A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci U S A 1987; 84: 48314835.
  • 52
    Hawkes R, Niday E, Gordon J. A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem 1982; 119: 1242147.
  • 53
    Bennet FC, Yeoman LC. An improved procedure for the “dot-immunobinding” analysis of hybridoma supernatants. J Immunol Meth 1983; 61: 201207.
  • 54
    Maurer HR. Towards chemically-defined, serum-free media for mammalian cell culture. In: FreshneyRI, ed. Animal Cell Culture: A Practical Approach. Oxford: IRL Press, 1986: 1331.
  • 55
    Martin DM, Feldman EL. Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells. J Cell Physiol 1993; 155: 290300.
  • 56
    Raile K, Hoflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, et al. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. J Cell Physiol 1994; 159: 531541.
  • 57
    Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/ mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinology 1990; 4: 13271335.
  • 58
    Thornton WH Jr, Barnett L, MacDonald RS. Insulin-like growth factor-II expression in normal and JV-methyl-JV'-nitro-JV-nitrosoguanidine exposed cell lines: assessment by flow cytometry. In Vitro Cell Dev Biol 1993; 29A: 114116.
  • 59
    Zvibel I, Brill S, Reid LM. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas. J Cell Physiol 1995; 162: 3643.
  • 60
    Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, et al. Tumorigenicity of the met-proto- oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 1992; 12: 51525158.
  • 61
    Kanda H, Tajima H, Lee G-H, Nomura K, Ohtake K, Matsumoto K, Nakamura T, et al. Hepatocyte growth factor transforms immortalized mouse liver epithelial cells. Oncogene 1993; 8: 30473053.
  • 62
    Zapf J, Schoenle E, Froesch ER. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem 1978; 87: 285296.
  • 63
    Widmer U, Schmid C, Zapf J, Froesch ER. Effects of insulin-like growth factors on chick embryo hepatocytes. Acta Endocrinologica 1985; 108: 237244.
  • 64
    Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell 1991; 64: 271280.
  • 65
    Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 7679.
  • 66
    Sirica AE, Mathis GA, Sano N, Elmore LW. Isolation, culture and transplantation of intrahepatic biliary epithelial cells and oval cells. Pathobiology 1990; 58: 4464.
  • 67
    Aterman K. The stem cells of the liver–a selective review. J Cancer Res Clin Oncol 1992; 118: 87115.
  • 68
    Yang L, Faris RA, Hixson DC. Phenotypic heterogeneity within clonogenic ductal cell populations isolated from normal adult rat liver. Proc Soc Exp Biol Med 1993; 204: 280288.